HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates MiMedx Group (NASDAQ:MDXG) with a Buy and maintains $8 price target.
Xi Jinping’s Second-In-Command Projects Confidence At Davos: ‘Chinese Economy Can Handle Ups And Downs’
At the World Economic Forum in Davos, China's second-in-command, Li Qiang, reassured global leaders about the resilience of the Chinese economy, stating it can handle fluctuations amidst current global challenges.